Correlation Between Ascelia Pharma and Bavarian Nordic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ascelia Pharma and Bavarian Nordic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascelia Pharma and Bavarian Nordic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ascelia Pharma AB and Bavarian Nordic, you can compare the effects of market volatilities on Ascelia Pharma and Bavarian Nordic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascelia Pharma with a short position of Bavarian Nordic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascelia Pharma and Bavarian Nordic.

Diversification Opportunities for Ascelia Pharma and Bavarian Nordic

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Ascelia and Bavarian is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Ascelia Pharma AB and Bavarian Nordic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bavarian Nordic and Ascelia Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascelia Pharma AB are associated (or correlated) with Bavarian Nordic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bavarian Nordic has no effect on the direction of Ascelia Pharma i.e., Ascelia Pharma and Bavarian Nordic go up and down completely randomly.

Pair Corralation between Ascelia Pharma and Bavarian Nordic

Assuming the 90 days trading horizon Ascelia Pharma AB is expected to generate 0.77 times more return on investment than Bavarian Nordic. However, Ascelia Pharma AB is 1.3 times less risky than Bavarian Nordic. It trades about 0.35 of its potential returns per unit of risk. Bavarian Nordic is currently generating about 0.0 per unit of risk. If you would invest  255.00  in Ascelia Pharma AB on September 13, 2024 and sell it today you would earn a total of  78.00  from holding Ascelia Pharma AB or generate 30.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Ascelia Pharma AB  vs.  Bavarian Nordic

 Performance 
       Timeline  
Ascelia Pharma AB 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Ascelia Pharma AB are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating technical and fundamental indicators, Ascelia Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.
Bavarian Nordic 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bavarian Nordic has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Ascelia Pharma and Bavarian Nordic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ascelia Pharma and Bavarian Nordic

The main advantage of trading using opposite Ascelia Pharma and Bavarian Nordic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascelia Pharma position performs unexpectedly, Bavarian Nordic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bavarian Nordic will offset losses from the drop in Bavarian Nordic's long position.
The idea behind Ascelia Pharma AB and Bavarian Nordic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios